• The FDA approved Leqembi (lecanemab) for the treatment of early-stage Alzheimer’s disease. Leqembi (lecanemab) is a treatment for people with mild cognitive impairment (MCI) or in the early stage of Alzheimer’s disease.
• This is the first traditionally approved treatment that changes the underlying course of the disease.
• By slowing progression of the disease when taken in the early stages of Alzheimer’s, individuals will have more time to participate in daily life and live independently.
Please donate to my team so we can find a total cure from this terrible disease.
http://act.alz.org/goto/TeamRedHotAnnie
